Download PDF
Thromb Haemost 1989; 62(04): 1126-1142
DOI: 10.1055/s-0038-1647131
Scientific and Standardization Committee Communications
Schattauer GmbH Stuttgart

Subcommittee on Clinical Trials: Registry of Multicenter Clinical Trials

Tenth Report - 1988
J P Boissel
The Unité de Pharmacologie Clinique, Hôpital Neuro-Cardiologique, Lyon, France
› Author Affiliations
Further Information

Publication History



Accepted for publication 12 September 1989

Publication Date:
24 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Verstraete M. Registry of prospective clinical trials. First report Thromb Diath Haemorrh 1975; 33: 655-663
    PubMedSearch in Google Scholar
  • 2 Verstraete M. Registry of prospective clinical trials. Second report Thromb Haemostas 1976; 36: 239-250
    PubMedSearch in Google Scholar
  • 3 Verstraete M. Registry of prospective clinical trials. Third report Thromb Haemostas 1978; 39: 759-767
    PubMedSearch in Google Scholar
  • 4 Verstraete M. Registry of prospective clinical trials. Fourth report Thromb Haemostas 1980; 43: 176-181
    PubMedSearch in Google Scholar
  • 5 Verstraete M. Registry of prospective clinical trials. Fifth report Thromb Haemostas 1982; 48: 334-338
    PubMedSearch in Google Scholar
  • 6 Verstraete M. Registry of prospective clinical trials. Sixth report Thromb Haemostas 1984; 51: 283-290
    PubMedSearch in Google Scholar
  • 7 Boissel J-P. Registry of multicenter clinical trials. Seventh report Thromb Haemostas 1986; 55: 282-291
    PubMedSearch in Google Scholar
  • 8 Boissel J-P. Registry of multicenter clinical trials. Eighth report Thromb Haemostas 1987; 57: 361-371
    PubMedSearch in Google Scholar
  • 9 Boissel J-P. Registry of multicenter clinical trials. Ninth report Thromb Haemostas 1988; 59: 107-119
    PubMedSearch in Google Scholar
  • 10 Boissel J-P, Peyrieux J-C, Destors J-M. Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower limbs. Thromb Haemostas 1989; 62: 681-685
    PubMedSearch in Google Scholar
  • 11 Dickersin K. Report from the Panel on the Case for Registers of Clinical Trials at the Eighth Annual Meeting of the Society for Clinical Trials. panelists: Chalmer TC, Simes RJ, Dickersin K, Boissel J-P, Meinert CL. Controlled Clinical Trials 1988; 09: 76-81
    CrossrefPubMedSearch in Google Scholar
  • 12 ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360
    PubMedSearch in Google Scholar
  • 13 Moss AJ. The MDPI Research Group. Long-term effect of diltiazem on mortality and reinfarction after myocardial infarction: the MDPIT study (abstract) JACC 1988; 11: 27 A
    CrossrefPubMedSearch in Google Scholar
  • 14 Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318: 1162-1172
    CrossrefPubMedSearch in Google Scholar